| pubmed-article:11472468 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0162791 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0332307 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0025598 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0522473 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C1510802 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:11472468 | lifeskim:mentions | umls-concept:C0278329 | lld:lifeskim |
| pubmed-article:11472468 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11472468 | pubmed:dateCreated | 2001-7-26 | lld:pubmed |
| pubmed-article:11472468 | pubmed:abstractText | To define the number of people in Tayside, Scotland (population 349 303) with Type 2 diabetes who use metformin, the incidence of contraindications to its continued use in these people and the proportion that discontinued metformin treatment following the development of a contraindication. | lld:pubmed |
| pubmed-article:11472468 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11472468 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11472468 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11472468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11472468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11472468 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11472468 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11472468 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:11472468 | pubmed:issn | 0742-3071 | lld:pubmed |
| pubmed-article:11472468 | pubmed:author | pubmed-author:EvansJ MJM | lld:pubmed |
| pubmed-article:11472468 | pubmed:author | pubmed-author:MorrisA DAD | lld:pubmed |
| pubmed-article:11472468 | pubmed:author | pubmed-author:SullivanFF | lld:pubmed |
| pubmed-article:11472468 | pubmed:author | pubmed-author:Emslie-SmithA... | lld:pubmed |
| pubmed-article:11472468 | pubmed:author | pubmed-author:BoyleD IDI | lld:pubmed |
| pubmed-article:11472468 | pubmed:author | pubmed-author:DARTS/MEMO... | lld:pubmed |
| pubmed-article:11472468 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11472468 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:11472468 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11472468 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11472468 | pubmed:pagination | 483-8 | lld:pubmed |
| pubmed-article:11472468 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:meshHeading | pubmed-meshheading:11472468... | lld:pubmed |
| pubmed-article:11472468 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11472468 | pubmed:articleTitle | Contraindications to metformin therapy in patients with Type 2 diabetes--a population-based study of adherence to prescribing guidelines. | lld:pubmed |
| pubmed-article:11472468 | pubmed:affiliation | Tayside Centre for General Practice, Ninewells Hospital and Medical School, Dundee, Scotland, UK. aemslie-smith@fintry.finix.org.uk | lld:pubmed |
| pubmed-article:11472468 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11472468 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11472468 | lld:pubmed |
